Action on Hearing Loss Logo
    Total results:
    Search
      Total results:

      Translational Research Initiative for Hearing

      Across the UK 11 million people have hearing loss. Around one in 10 adults live with tinnitus.

      But, despite this high medical need, there are no clinically approved treatments or cures. Yet.

      We are determined to change this. We support translational research – where promising discoveries move from the laboratory into clinical trials. Our TRIH initiative has four key components:

      • Funding
      • Consultancy
      • Working with Partners
      • Engaging with patients.

      In this section we explain how we can help in each of these areas. You can find more information in our TRIH Brochure or by emailing trih@hearingloss.org.uk.

      TRIH Newsletter 

      Our bi-annual newsletter keeps you up to date with the latest opportunities in translational hearing research.

      The Translational Research Initiative for Hearing (TRIH) grant is international. We fund applied research projects based at research institutes and small-medium enterprises (SMEs) across the world.

      We have developed an extensive network of academic researchers, clinicians, investors and companies who work on hearing loss and tinnitus. We have a thorough understanding of the hearing loss and tinnitus markets. Find out more

      Our Translational Research Initiative for Hearing (TRIH) Partners are organisations that work with us to support the development of treatments for hearing loss and tinnitus.

      We are the leading UK hearing loss charity, benefiting from active members and volunteers. We have strong links to people confronting hearing loss and tinnitus, through our local support services, extensive social media networks, popular members' magazine and website.

      22 March 2018, Wellcome Collection (Henry Wellcome Auditorium) London 

      Before a drug can be made available to the public it has to go through rigorous clinical trials, in people, to test whether it is safe and effective. To make sure these vital trials happen, we help companies engage with people with hearing loss and tinnitus (and help these people take part).

      TRIH helps developers get their research to a point where it could attract the commercial funding necessary to take treatments to market. We need your support to invest more, in this promising, life-changing research across the world.